45 related articles for article (PubMed ID: 12424609)
1. Antitumor effects and radiosensitization of cytosine deaminase and thymidine kinase fusion suicide gene on colorectal carcinoma cells.
Wu DH; Liu L; Chen LH
World J Gastroenterol; 2005 May; 11(20):3051-5. PubMed ID: 15918188
[TBL] [Abstract][Full Text] [Related]
2. Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.
Lee KC; Hamstra DA; Bullarayasamudram S; Bhojani MS; Moffat BA; Dornfeld KJ; Ross BD; Rehemtulla A
Gene Ther; 2006 Jan; 13(2):127-37. PubMed ID: 16163381
[TBL] [Abstract][Full Text] [Related]
3. Generation and functional characterization of a multigene-modified NK101 cell line exerting diverse mechanisms of antitumor action.
Hwang I; Jin HT; Kang MC; Kim TY; Sung YC; Kim SW
Oncoimmunology; 2022; 11(1):2014655. PubMed ID: 36524207
[TBL] [Abstract][Full Text] [Related]
4. New frontiers and developing applications in 19F NMR.
Yu JX; Hallac RR; Chiguru S; Mason RP
Prog Nucl Magn Reson Spectrosc; 2013 Apr; 70():25-49. PubMed ID: 23540575
[No Abstract] [Full Text] [Related]
5. Expression of the bifunctional suicide gene CDUPRT increases radiosensitization and bystander effect of 5-FC in prostate cancer cells.
Xing L; Sun X; Deng X; Kotedia K; Urano M; Koutcher JA; Ling CC; Li GC
Radiother Oncol; 2009 Sep; 92(3):345-52. PubMed ID: 19433338
[TBL] [Abstract][Full Text] [Related]
6. A 19F-NMR approach using reporter molecule pairs to assess beta-galactosidase in human xenograft tumors in vivo.
Yu JX; Kodibagkar VD; Liu L; Mason RP
NMR Biomed; 2008 Aug; 21(7):704-12. PubMed ID: 18288788
[TBL] [Abstract][Full Text] [Related]
7. Efficient syntheses of 5'-deoxy-5'-fluoroguanosine and -inosine.
Spitale RC; Heller MG; Pelly AJ; Wedekind JE
J Org Chem; 2007 Oct; 72(22):8551-4. PubMed ID: 17902696
[TBL] [Abstract][Full Text] [Related]
8. Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model.
Wang W; Tai CK; Kershaw AD; Solly SK; Klatzmann D; Kasahara N; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E25. PubMed ID: 16709031
[TBL] [Abstract][Full Text] [Related]
9. Current progress in suicide gene therapy for cancer.
Yazawa K; Fisher WE; Brunicardi FC
World J Surg; 2002 Jul; 26(7):783-9. PubMed ID: 11948367
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer.
Niculescu-Duvaz I; Cooper RG; Stribbling SM; Heyes JA; Metcalfe JA; Springer CJ
Curr Opin Mol Ther; 1999 Aug; 1(4):480-6. PubMed ID: 11713763
[TBL] [Abstract][Full Text] [Related]
11. Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy.
Corban-Wilhelm H; Hull WE; Becker G; Bauder-Wüst U; Greulich D; Debus J
Gene Ther; 2002 Dec; 9(23):1564-75. PubMed ID: 12424609
[TBL] [Abstract][Full Text] [Related]
12. Cytosine deaminase versus thymidine kinase: a comparison of the antitumor activity.
Corban-Wilhelm H; Becker G; Bauder-Wüst U; Greulich D; Debus J
Clin Exp Med; 2003 Nov; 3(3):150-6. PubMed ID: 14648229
[TBL] [Abstract][Full Text] [Related]
13. Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine.
Lawrence TS; Rehemtulla A; Ng EY; Wilson M; Trosko JE; Stetson PL
Cancer Res; 1998 Jun; 58(12):2588-93. PubMed ID: 9635583
[TBL] [Abstract][Full Text] [Related]
14. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy.
Corban-Wilhelm H; Ehemann V; Becker G; Greulich D; Braun K; Debus J
Cancer Gene Ther; 2004 Mar; 11(3):208-14. PubMed ID: 14671673
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
